156 related articles for article (PubMed ID: 26157485)
21. The Genomic Landscape of PAX5, IKZF1, and CDKN2A/B Alterations in B-Cell Precursor Acute Lymphoblastic Leukemia.
Ou Z; Sherer M; Casey J; Bakos HA; Vitullo K; Hu J; Friehling E; Gollin SM; Surti U; Yatsenko SA
Cytogenet Genome Res; 2016; 150(3-4):242-252. PubMed ID: 28214896
[TBL] [Abstract][Full Text] [Related]
22. The reduced and altered activities of PAX5 are linked to the protein-protein interaction motif (coiled-coil domain) of the PAX5-PML fusion protein in t(9;15)-associated acute lymphocytic leukemia.
Qiu JJ; Chu H; Lu X; Jiang X; Dong S
Oncogene; 2011 Feb; 30(8):967-77. PubMed ID: 20972455
[TBL] [Abstract][Full Text] [Related]
23. Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia.
Li J; Dai Y; Wu L; Zhang M; Ouyang W; Huang J; Chen S
Front Med; 2021 Jun; 15(3):347-371. PubMed ID: 33400146
[TBL] [Abstract][Full Text] [Related]
24. PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia.
Gu Z; Churchman ML; Roberts KG; Moore I; Zhou X; Nakitandwe J; Hagiwara K; Pelletier S; Gingras S; Berns H; Payne-Turner D; Hill A; Iacobucci I; Shi L; Pounds S; Cheng C; Pei D; Qu C; Newman S; Devidas M; Dai Y; Reshmi SC; Gastier-Foster J; Raetz EA; Borowitz MJ; Wood BL; Carroll WL; Zweidler-McKay PA; Rabin KR; Mattano LA; Maloney KW; Rambaldi A; Spinelli O; Radich JP; Minden MD; Rowe JM; Luger S; Litzow MR; Tallman MS; Racevskis J; Zhang Y; Bhatia R; Kohlschmidt J; Mrózek K; Bloomfield CD; Stock W; Kornblau S; Kantarjian HM; Konopleva M; Evans WE; Jeha S; Pui CH; Yang J; Paietta E; Downing JR; Relling MV; Zhang J; Loh ML; Hunger SP; Mullighan CG
Nat Genet; 2019 Feb; 51(2):296-307. PubMed ID: 30643249
[TBL] [Abstract][Full Text] [Related]
25. PAX5 is part of a functional transcription factor network targeted in lymphoid leukemia.
Okuyama K; Strid T; Kuruvilla J; Somasundaram R; Cristobal S; Smith E; Prasad M; Fioretos T; Lilljebjörn H; Soneji S; Lang S; Ungerbäck J; Sigvardsson M
PLoS Genet; 2019 Aug; 15(8):e1008280. PubMed ID: 31381561
[TBL] [Abstract][Full Text] [Related]
26. FOXP1 and PAX5 are rare but recurrent translocations partners in acute lymphoblastic leukemia.
Put N; Deeren D; Michaux L; Vandenberghe P
Cancer Genet; 2011 Aug; 204(8):462-4. PubMed ID: 21962897
[TBL] [Abstract][Full Text] [Related]
27. PAX5-ESRRB is a recurrent fusion gene in B-cell precursor pediatric acute lymphoblastic leukemia.
Marincevic-Zuniga Y; Zachariadis V; Cavelier L; Castor A; Barbany G; Forestier E; Fogelstrand L; Heyman M; Abrahamsson J; Lönnerholm G; Nordgren A; Syvänen AC; Nordlund J
Haematologica; 2016 Jan; 101(1):e20-3. PubMed ID: 26494837
[No Abstract] [Full Text] [Related]
28. PAX5 alterations in genetically unclassified childhood Precursor B-cell acute lymphoblastic leukaemia.
Stasevich I; Inglott S; Austin N; Chatters S; Chalker J; Addy D; Dryden C; Ancliff P; Ford A; Williams O; Kempski H
Br J Haematol; 2015 Oct; 171(2):263-272. PubMed ID: 26115422
[TBL] [Abstract][Full Text] [Related]
29. Transcriptome sequencing in pediatric acute lymphoblastic leukemia identifies fusion genes associated with distinct DNA methylation profiles.
Marincevic-Zuniga Y; Dahlberg J; Nilsson S; Raine A; Nystedt S; Lindqvist CM; Berglund EC; Abrahamsson J; Cavelier L; Forestier E; Heyman M; Lönnerholm G; Nordlund J; Syvänen AC
J Hematol Oncol; 2017 Aug; 10(1):148. PubMed ID: 28806978
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases.
Li JF; Dai YT; Lilljebjörn H; Shen SH; Cui BW; Bai L; Liu YF; Qian MX; Kubota Y; Kiyoi H; Matsumura I; Miyazaki Y; Olsson L; Tan AM; Ariffin H; Chen J; Takita J; Yasuda T; Mano H; Johansson B; Yang JJ; Yeoh AE; Hayakawa F; Chen Z; Pui CH; Fioretos T; Chen SJ; Huang JY
Proc Natl Acad Sci U S A; 2018 Dec; 115(50):E11711-E11720. PubMed ID: 30487223
[TBL] [Abstract][Full Text] [Related]
31. Preserved global histone H4 acetylation linked to ETV6-RUNX1 fusion and PAX5 deletions is associated with favorable outcome in pediatric B-cell progenitor acute lymphoblastic leukemia.
Janczar K; Janczar S; Pastorczak A; Mycko K; Paige AJ; Zalewska-Szewczyk B; Wagrowska-Danilewicz M; Danilewicz M; Mlynarski W
Leuk Res; 2015 Dec; 39(12):1455-61. PubMed ID: 26520622
[TBL] [Abstract][Full Text] [Related]
32. Pax5: a master regulator of B cell development and leukemogenesis.
Medvedovic J; Ebert A; Tagoh H; Busslinger M
Adv Immunol; 2011; 111():179-206. PubMed ID: 21970955
[TBL] [Abstract][Full Text] [Related]
33. New oncogenic subtypes in pediatric B-cell precursor acute lymphoblastic leukemia.
Lilljebjörn H; Fioretos T
Blood; 2017 Sep; 130(12):1395-1401. PubMed ID: 28778863
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of multiplex ligation-dependent probe amplification as a method for the detection of copy number abnormalities in B-cell precursor acute lymphoblastic leukemia.
Schwab CJ; Jones LR; Morrison H; Ryan SL; Yigittop H; Schouten JP; Harrison CJ
Genes Chromosomes Cancer; 2010 Dec; 49(12):1104-13. PubMed ID: 20815030
[TBL] [Abstract][Full Text] [Related]
35. The PAX5-JAK2 translocation acts as dual-hit mutation that promotes aggressive B-cell leukemia via nuclear STAT5 activation.
Jurado S; Fedl AS; Jaritz M; Kostanova-Poliakova D; Malin SG; Mullighan CG; Strehl S; Fischer M; Busslinger M
EMBO J; 2022 Apr; 41(7):e108397. PubMed ID: 35156727
[TBL] [Abstract][Full Text] [Related]
36. Transcriptional and Mutational Profiling of B-Other Acute Lymphoblastic Leukemia for Improved Diagnostics.
Chouvarine P; Antić Ž; Lentes J; Schröder C; Alten J; Brüggemann M; Carrillo-de Santa Pau E; Illig T; Laguna T; Schewe D; Stanulla M; Tang M; Zimmermann M; Schrappe M; Schlegelberger B; Cario G; Bergmann AK
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830809
[TBL] [Abstract][Full Text] [Related]
37. PAX5 deletion is common and concurrently occurs with CDKN2A deletion in B-lineage acute lymphoblastic leukemia.
Kim M; Choi JE; She CJ; Hwang SM; Shin HY; Ahn HS; Yoon SS; Kim BK; Park MH; Lee DS
Blood Cells Mol Dis; 2011 Jun; 47(1):62-6. PubMed ID: 21549623
[TBL] [Abstract][Full Text] [Related]
38. Case Report: The Formation of a Truncated PAX5 Transcript in a Case of Ph-Positive Mixed Phenotype Acute Leukemia With dic(7;9)(p11-p13;p13).
Yu Y; Zeng Z; Xie J; Lu Q; Cai W; Zhang R; Pan J; Zhao Y; Sun A; Qiu H; Chen S
Front Oncol; 2021; 11():703612. PubMed ID: 34513684
[TBL] [Abstract][Full Text] [Related]
39. LCK over-expression drives STAT5 oncogenic signaling in PAX5 translocated BCP-ALL patients.
Cazzaniga V; Bugarin C; Bardini M; Giordan M; te Kronnie G; Basso G; Biondi A; Fazio G; Cazzaniga G
Oncotarget; 2015 Jan; 6(3):1569-81. PubMed ID: 25595912
[TBL] [Abstract][Full Text] [Related]
40. PAX5/ETV6 fusion defines cytogenetic entity dic(9;12)(p13;p13).
Strehl S; König M; Dworzak MN; Kalwak K; Haas OA
Leukemia; 2003 Jun; 17(6):1121-3. PubMed ID: 12764378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
